Ali’s research interests focus on biomaterials engineering for the development of immunotherapies. He specifically works on designing cell-instructive systems that enable the study and control of immune processes. He completed his Ph.D. in 2008 at Harvard University, where he designed materials to act as infection mimics and to program immune cells in situ. Ali initiated a collaboration with scientists at the Dana Farber Cancer Institute to develop these material systems into cancer vaccines that eradicated melanoma tumors in mice. Prior to joining the Wyss, Ali was the founding scientist at a start-up and conducted NIH-funded, preclinical work on vaccine designs for brain cancer. His prior research includes the fabrication of adhesive substrates and the development of wound healing models. Omar received his B.S.E. in chemical engineering at the University of Minnesota, and earned his Ph.D. in engineering sciences at Harvard University.